未登录

Z

Zhou, Jianfeng

chinese academy of medical sciences - peking union medical college

H指数:0

被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advances in plant phenotyping for more sustainable crop production

COMPUTERS AND ELECTRONICS IN AGRICULTURE

IF8.9

2023-05-010

PRE

Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells (vol 16, pg 5165, 2010)

CLINICAL CANCER RESEARCH

IF10.2

2022-10-140

OA

Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model (vol 9, pg 1153, 2014)

CANCER BIOLOGY & THERAPY

IF4.6

2020-11-090

OAAI

Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies

具有嵌合抗原受体-细胞外囊泡的CRISPR/Cas9系统对b细胞恶性肿瘤的趋向性促进递送

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-10-0164

PREAI

CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-04-2816

OAAI

Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells (Expression of Concern of Vol 16, Pg 5165, 2010)

CLINICAL CANCER RESEARCH

IF10.2

2020-03-131

PREAI

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2019-10-2248

OAAI

Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2019-04-0415

OAAI

A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy

自体CAR T细胞治疗失败后，难治性mantel细胞淋巴瘤对单倍体CAR T细胞治疗的良好反应

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2019-02-2115

OAAI

Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells

CLINICAL CANCER RESEARCH

IF10.2

2014-12-1451

OAAI

Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD

JOURNAL OF CONTROLLED RELEASE

IF11.5

2012-08-0141

PREAI

Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells (Publication with Expression of Concern. See vol. 26, pg. 1530, 2020)

CLINICAL CANCER RESEARCH

IF10.2

2010-11-0116

OAAI

The universal overexpression of a cancer testis antigen hiwi is associated with cancer angiogenesis

ONCOLOGY REPORTS

IF3.9

2010-03-0436

OA

5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro

ONCOLOGY REPORTS

IF3.9

2009-11-2373

OAAI

Isolation and characterization of lymphatic endothelial cells from human glossal lymphangioma

ONCOLOGY REPORTS

IF3.9

2009-11-238

OAAI

TMTP1, a novel tumor-homing peptide specifically targeting metastasis

CLINICAL CANCER RESEARCH

IF10.2

2008-09-02110

OAAI

Biliverdin reductase mediates hypoxia-induced EMT via PI3-Kinase and Akt

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF9.4

2008-02-0174

OAAI

Expression of TMEM87B interacting with the human papillomavirus type 18 E6 oncogene in the Hela cDNA library by a yeast two-hybrid system

ONCOLOGY REPORTS

IF3.9

1994-01-018

OAAI

The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts

ONCOLOGY REPORTS

IF3.9

1994-01-019

OAAI